seed
Stage
1
Investors
About
Advemto develops technology that maps complex cell functions to genetic sequences at scale, aiming to remove bottlenecks in preclinical validation processes for next-generation therapeutics without the need for new instruments.
Explore Advemto's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.